{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:13:23Z","timestamp":1789665203007,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejogrb.2025.114539","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T19:57:23Z","timestamp":1750276643000},"page":"114539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Decoding placental dysfunction with a new angiogenic classification of PlGF and sFlt-1"],"prefix":"10.1016","volume":"312","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6010-9994","authenticated-orcid":false,"given":"Valentina","family":"Giardini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice AF","family":"Santagati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Marelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Casati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cantarutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejogrb.2025.114539_b0005","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41574-020-0372-6","article-title":"Tracking placental development in health and disease","volume":"16","author":"Aplin","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"381","key":"10.1016\/j.ejogrb.2025.114539_b0010","article-title":"Hypertensive disorders of pregnancy","volume":"30","author":"Wu","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2025.114539_b0015","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists. Fetal Growth Restriction: ACOG Practice Bulletin No.\u00a0227. Obstet Gynecol. 2021\u00a0Feb\u00a01;137(2):e16\u2013e28. doi:\u00a0https:\/\/doi.org\/10.1097\/AOG.0000000000004251. PMID:\u00a033481528.","DOI":"10.1097\/AOG.0000000000004251"},{"issue":"7","key":"10.1016\/j.ejogrb.2025.114539_b0020","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/14767058.2019.1624718","article-title":"Management of pregnancy blood pressure increase in the emergency room: role of PlGF based biochemical markers and relative economic impact","volume":"34","author":"Giardini","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"9","key":"10.1016\/j.ejogrb.2025.114539_b0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11906-020-01082-w","article-title":"Prevention, diagnosis, and management of hypertensive disorders of pregnancy: a comparison of international guidelines","volume":"22","author":"Sinkey","year":"2020","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114539_b0030","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ajog.2021.11.1357","article-title":"Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach","volume":"226","author":"Lees","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114539_b0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ajog.2017.06.011","article-title":"Health and economic burden of preeclampsia: no time for complacency","volume":"217","author":"Li","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl","key":"10.1016\/j.ejogrb.2025.114539_b0040","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.placenta.2011.11.021","article-title":"Review: biochemical markers to predict preeclampsia","volume":"33","author":"Anderson","year":"2012","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.114539_b0045","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1093\/advances\/nmab070","article-title":"Placental angiogenesis in mammals: a review of the regulatory effects of signaling pathways and functional nutrients","volume":"12","author":"Huang","year":"2021","journal-title":"Adv Nutr"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114539_b0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10456-019-09694-w","article-title":"Reconciling the distinct roles of angiogenic\/anti angiogenic factors in the placenta and maternal circulation of normal and pathological pregnancies","volume":"23","author":"Umapathy","year":"2020","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ejogrb.2025.114539_b0055","doi-asserted-by":"crossref","unstructured":"Lecarpentier \u00c9, Vieillefosse S, Haddad B, Fournier T, Leguy MC, Guibourdenche J, et al. Placental growth factor (PlGF) and sFlt-1 during pregnancy: physiology, assay and interest in preeclampsia. Ann Biol Clin (Paris). 2016;74(3):259-67. English. doi: 10.1684\/abc.2016.1158. PMID: 27237799.","DOI":"10.1684\/abc.2016.1158"},{"key":"10.1016\/j.ejogrb.2025.114539_b0060","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejogrb.2025.114539_b0065","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ejogrb.2025.114539_b0070","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.3390\/v14102207","article-title":"Imbalanced angiogenesis in pregnancies complicated by SARS-CoV-2 infection","volume":"14","author":"Giardini","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ejogrb.2025.114539_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.placenta.2016.03.010","article-title":"Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction","volume":"42","author":"Benton","year":"2016","journal-title":"Placenta"},{"key":"10.1016\/j.ejogrb.2025.114539_b0080","unstructured":"NICE Diagnostic Guidance DG23. PlGF based testing to help diagnose suspected preeclampsia: Triage PlGF test, Elecsys immunoassay sFlt 1\/PlGF ratio, DELFIA Xpress PlGF 1-2-3 test, and BRAHMS sFlt 1 Kryptor\/BRAHMS PlGF plus Kryptor PE ratio. London: National Institute for Health and Care Excellence (NICE); May\u00a02016."},{"key":"10.1016\/j.ejogrb.2025.114539_b0085","doi-asserted-by":"crossref","unstructured":"Herraiz I, Llurba E, Verlohren S, Galindo A; Spanish Group for the Study of Angiogenic Markers in Preeclampsia. Update on the diagnosis and prognosis of preeclampsia with the aid of the sFlt-1\/PlGF ratio in singleton pregnancies. Fetal Diagn Ther 2018;43(2):81-89. doi: 10.1159\/000477903. Epub 2017 Jul 19. PMID: 28719896.","DOI":"10.1159\/000477903"},{"key":"10.1016\/j.ejogrb.2025.114539_b0090","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejogrb.2024.07.042","article-title":"Does the use of angiogenic biomarkers for the management of preeclampsia and fetal growth restriction improve outcomes?: Challenging the current status quo","volume":"300","author":"Ramirez Zegarra","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114539_b0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114539_b0100","doi-asserted-by":"crossref","first-page":"58.e1","DOI":"10.1016\/j.ajog.2011.07.037","article-title":"The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients","volume":"206","author":"Verlohren","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"2 Pt 1","key":"10.1016\/j.ejogrb.2025.114539_b0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/AOG.0000000000000367","article-title":"Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction","volume":"124","author":"Herraiz","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114539_b0110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/10641955.2017.1334800","article-title":"Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction","volume":"36","author":"Shinohara","year":"2017","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ejogrb.2025.114539_b0115","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/aogs.14546","article-title":"The sFlt1\/PlGF ratio predicts faster fetal deterioration in early fetal growth restriction: a historical cohort study","volume":"102","author":"Palma dos Reis","year":"2023","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114539_b0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/aogs.13978","article-title":"Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age","volume":"100","author":"Garcia-Manau","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2025.114539_b0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.preghy.2021.12.003","article-title":"Clinical interpretation and implementation of the sFlt-1\/PlGF ratio in the prediction, diagnosis and management of preeclampsia","volume":"27","author":"Verlohren","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ejogrb.2025.114539_b0130","doi-asserted-by":"crossref","unstructured":"Giardini V, Grilli L, Terzaghi A, et al. sFlt-1 Levels as a Predicting Tool in Placental Dysfunction Complications in Multiple Pregnancies. Biomedicines. 2023;11(11):2917. Published 2023 Oct 28. doi:10.3390\/biomedicines11112917.","DOI":"10.3390\/biomedicines11112917"},{"key":"10.1016\/j.ejogrb.2025.114539_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.preghy.2024.101149","article-title":"Letter to the editor: caution: not all sFlt-1\/PlGF ratios are the same","volume":"37","author":"Giardini","year":"2024","journal-title":"Pregnancy Hypertens"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.114539_b0140","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1097\/AOG.0000000000003892","article-title":"ACOG Practice Bulletin Summary, Number 222","volume":"135","author":"Gestational Hypertension and Preeclampsia","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114539_b0145","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: a Delphi procedure","volume":"48","author":"Gordijn","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114539_b0150","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MPG.0b013e3181da213e","article-title":"Neonatal anthropo metric charts: the Italian neonatal study compared with other European studies","volume":"51","author":"Bertino","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114539_b0155","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ejogrb.2025.114539_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2016.03.010","article-title":"Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction","volume":"42","author":"Benton","year":"2016","journal-title":"Placenta"},{"key":"10.1016\/j.ejogrb.2025.114539_b0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.preghy.2021.05.023","article-title":"Placental growth factor as a diagnostic tool for placental mediated fetal growth restriction","volume":"25","author":"Shinar","year":"2021","journal-title":"Pregnancy Hypertens"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.114539_b0170","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/HYPERTENSIONAHA.120.15830","article-title":"Angiogenic Factors and long-term cardiovascular risk in women that developed preeclampsia during pregnancy","volume":"76","author":"Garrido-Gimenez","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ejogrb.2025.114539_b0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.biochi.2023.04.005","article-title":"Fatty acids, inflammation and angiogenesis in women with gestational diabetes mellitus","volume":"212","author":"Joshi","year":"2023","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114539_b0180","first-page":"203","article-title":"Analogies between COVID-19 and preeclampsia: focus on therapies","volume":"3","author":"Giardini","year":"2023","journal-title":"Int J Transl Med"},{"issue":"7","key":"10.1016\/j.ejogrb.2025.114539_b0185","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3390\/jcm13071899","article-title":"Predicting time to delivery in hypertensive disorders: assessing PlGF and sFlt-1 with the novel parameter \u2018Mtp-multiples of a normal term placenta\u2019","volume":"13","author":"Giardini","year":"2024","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.ejogrb.2025.114539_b0190","first-page":"718","article-title":"sFlt-1\/PlGF ratio in prediction of short-term neonatal outcome of small for gestational age neonates","volume":"8","author":"Witwicki","year":"2021","journal-title":"Children (Basel)"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525008152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525008152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T14:28:40Z","timestamp":1753453720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211525008152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":38,"alternative-id":["S0301211525008152"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114539","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding placental dysfunction with a new angiogenic classification of PlGF and sFlt-1","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114539"}}